CaAKG Ya Sa Mata Berayen Sun Rayu Tsawon Lokaci Kuma Sun Kula Da Lafiya
Wani bincike da aka buga a mujallar Cell Metabolism a shekarar 2020 ya gano cewa ciyar da berayen da suka kai tsakiyar shekarunsu da abincin da ke ƙunshe da 2 % calcium alpha‑ketoglutarate (CaAKG) na iya ƙara tsawon rayuwar mata har zuwa 16.6 % da kuma rage alamun kumburi. Wannan sakamakon yana da ban sha'awa, amma dole ne mu tuna cewa binciken an yi shi ne a kan beraye kawai, ba a tabbatar da cewa zai yi tasiri iri ɗaya a jikin mutane ba.
Takaitaccen Bincike
Azar Asadi Shahmirzadi da ƙungiyarsa sun yi gwaji a kan berayen C57BL/6 a ƙungiyoyi biyu masu zaman kansu, kowanne ƙungiya na da kusan beraye 45 mata da 45 maza (jimlar 182). An fara ba su abincin da ke ɗauke da 2 % CaAKG (w/w) a rana ta 540, wadda ke nuni da tsakiyar shekarun jinsin berayen. Daga nan aka bibiyi tsawon rai, lafiyar dabbobin, da kuma yanayin rauni a kai‑kai.
Fara magani a tsakiyar shekarun dabbobi yana da muhimmanci, domin yawancin ƙoƙarin tsawaita rayuwa a dabbobi da mutane na farawa tun ƙuruciya. Hakan ya sa sakamakon da aka samu a wannan bincike ya fi daukar hankali, duk da haka ba ya ba mu wani tabbaci kai tsaye game da mutanen da suka kai tsakiyar shekaru.
Me Ya Sa Ake Zaɓar Alpha‑Ketoglutarate? – Alaka Da TCA Cycle
Alpha‑ketoglutarate (AKG) yana daga cikin muhimman sinadarai na zagayen tricarboxylic acid (TCA) ko Krebs cycle, wadda ke taimaka wa ƙwayoyin tantance abinci su zama makamashi. Jiki na samar da AKG da kansa, kuma matakan sa na sauyawa yayin azumi, motsa jiki, da tsufa – saboda haka ya zama jiga‑jiga tsakanin abinci da tsarin tsufa.
Wannan alaka ba ta nufin cewa ƙaruwa da AKG a abinci zai "dagar da tsufa" ba; yana nuna kawai cewa AKG na iya taka rawa a cikin hanyoyin da ke shafar tsufa. A cikin takardar, marubuta sun yi amfani da CaAKG, wato siffar calcium na AKG, maimakon AKG mai ‘yanci. Yadda calcium ke shiga da rarrabawa a jiki na da bambanci da na AKG kawai, kuma wannan ba a fayyace ba a cikin wannan bincike.
Sakamakon: Mata Sun Amfana Fiye Da Maza
| Rukuni | Jinsi | Ƙara Tsawon Rai (Matsakaici) | Ƙara Tsawon Rai (90th percentile) |
|---|---|---|---|
| 1 | Mata | +16.6 % | +19.7 % |
| 1 | Maza | +9.6 % – +12.8 % (ba a ƙididdiga ba) | – |
| 2 | Mata | +10.5 % | +8 % |
| 2 | Maza | Ba a samu tasiri mai ƙididdiga ba | – |
A ƙungiyar ta farko, mata sun samu mafi girman ƙaruwa – 16.6 % a matsakaicin tsawon rai da 19.7 % a cikin 90th percentile. A ƙungiyar ta biyu, ƙaruwa ta ragu zuwa 10.5 % (mata) da 8 % (90th percentile). A maza, duk da cewa an samu ƙaruwa kaɗan (9.6 %–12.8 %), ba ta kai matakin da ya zama ƙididdiga ba, don haka ba za a iya ɗaukar ta a matsayin tasiri tabbatacce ba.
Rage "Compression of Morbidity"
Marubutan sun bayyana cewa CaAKG ba kawai ya ƙara tsawon rai ba, har ma ya rage lokacin da dabbobi ke cikin yanayin rashin lafiya – abin da ake kira "compression of morbidity". Ma’anar wannan ita ce: lokutan ƙarshe na rayuwa suna kasancewa mafi koshin lafiya, maimakon tsawaita shekaru da aka cike da cututtuka.
Wannan yana da muhimmanci a fannin tsawaita rayuwa, domin burin ainihi shi ne rayuwa mai ɗorewa da lafiya ba wai kawai samun ƙarin shekaru ba.
Inflammaging Da IL‑10
Berayen da aka ci gaba da CaAKG sun nuna ƙarancin matakan cytokines masu haifar da kumburi (misali TNF‑α, IL‑6) da kuma ƙaruwa a matakin IL‑10, cytokine da ke rage kumburi. Wannan yana nuni da cewa CaAKG na iya rage inflammaging – wato ci gaba da ƙananan matakan kumburi da ke haifar da lalacewar ƙwayoyin yayin tsufa.
Sai dai, hujjar da ake amfani da ita a cikin takardar itace hujja daga beraye, ba a tabbatar da cewa ɗan adam zai samu irin wannan tasiri ba. A halin yanzu, tambayar ita ce: shin shan CaAKG zai iya inganta yanayin kumburi a manya masu tsufa? Har yanzu babu amsar da aka tabbatar.
Talla vs. Abinda Takarda Ke Gaskata
| Maganar Tallace‑tallace | Abin Da Takarda Ta Gaskata |
|---|---|
| "An tabbatar da ƙara tsawon rai" | An ƙara tsawon rayuwar berayen C57BL/6 mata; maza ba su samu ƙaruwa mai ƙididdiga ba. Babu hujja a kan ɗan adam. |
| "Yana dawo da tsufa" | Takarda ta nuna raguwa a rauni da rage lokacin rashin lafiya a beraye, ba a nuna canjin tsufa a kowanne irin jiki ba. |
| "An tabbatar a cikin mutane" | Ba a yi gwajin a kan mutane ba. Sakamakon na dabbobi ne kawai. |
| "Matsakaicin ƙima ita ce 2 %" | 2 % w/w na CaAKG a abincin beraye – ba a tantance irin wannan ƙima a wajen mutane ba. |
| "Ya dace ga kowa" | Tasirin ya bambanta tsakanin jinsi, kuma an yi gwaji ne a kan nau’in beraye guda ɗaya. |
Limitations Da Ya Kamata A Lura Da Su
- Bincike a kan beraye ne kawai – ba za a iya ɗaukar sakamakon a matsayin hujja ga ɗan adam ba.
- Babu ƙimar da ta tabbatar a mutane – 2 % CaAKG a abincin beraye ba ya nufin wannan ƙima za ta yi aiki a jikin mutum.
- Tasirin jinsi – mata sun samu ƙaruwa mai ma’ana, maza ba su kai ga ƙididdiga ba.
- Bambancin ƙungiya – tasiri ya sauka daga 16.6 % zuwa 10.5 % tsakanin ƙungiyoyi biyu.
- IL‑10 a matsayin hujja – ƙara IL‑10 yana iya zama alaƙa, amma ba a tabbatar da shi a matsayin dalilin ƙara tsawon rai ba.
Takeaway: Jerin Sa‑ido Na Bincike, Ba Magani Ba
Ga masu bibiyar kimiyyar tsawaita rayuwa, CaAKG yana kan jerin sa‑ido – yana da alamu na tasiri a cikin berayen mata, kuma yana nuna alamar rage kumburi da rauni. Amma har yanzu akwai buƙatar:
- Maimaita binciken a kan nau’o’in beraye daban‑daban da ƙara yawan dabbobi.
- Binciken yadda CaAKG ke shiga jiki (pharmacokinetics) da yadda yake aiki (pharmacodynamics).
- Gwaje‑gwajen klinik na mutane da za su tantance amincinsa, amfaninsa, da kuma haɗarin sa.
Har zuwa lokacin, ba za a iya ɗaukar wannan takarda a matsayin tushen anti‑aging ga mutane ba. Duk wanda ke tunanin ƙara CaAKG ko wani karin sinadari, musamman masu ciwon da ke shan magani, ya kamata ya tuntuɓi likita kafin yin hakan.
Taƙaitaccen bayani: CaAKG ya ƙara tsawon rai da ya rage rauni a berayen mata, amma fa’idar tsawaita rayuwar ɗan adam har yanzu ba a tabbatar da ita ba.
